Migraine and epilepsy: Genetically linked?

Expert Review of Neurotherapeutics

Volumn 8, Issue 9, 2008, Pages 1307-1311

  Haan, Joost ^a,b   Van Den Maagdenberg, Arn M J M ^a   Brouwer, Oebele F ^c   Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Epilepsy; Familial hemiplegic migraine; Genetic; Glutamate; Ion transporter; Migraine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMITRIPTYLINE; ANTICONVULSIVE AGENT; METHYSERGIDE; PROPRANOLOL; PROTEIN ATP1A2; PROTEIN CACNA1A; PROTEIN SCN1A; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ANTICONVULSANT THERAPY; DRUG MECHANISM; DRUG TARGETING; EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; ION TRANSPORT; MIGRAINE; NERVE CELL EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SPREADING CORTICAL DEPRESSION;

ANIMALS; EPILEPSY; HUMANS; MIGRAINE DISORDERS;

EID: 51149117813     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.9.1307     Document Type: Review

References (38)

1. Haan J, Terwindt GM, van den Maagdenberg AMJM, Stam AH, Ferrari MD. A review of the genetic relation between migraine and epilepsy. Cephalalgia 28, 105-113 (2008). • Reviews clinical and genetic similarities of migraine and epilspsy
2. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology 44, 2105-2110 (1994).
3. Ludvigsson P, Hesdorffer D, Olafsson E, Kjartansson O, Hauser WA. Migraine with aura is a risk factor for unprovoked seizures in children. Ann. Neurol. 59, 210-213 (2006).
4. Van den Maagdenberg AMJM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr. Opin. Neurol. 20, 299-305 (2007). • An update of recent developments in the field of migraine genetics.
5. Headache classification subcommittee of the international headache society. The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 24 (Suppl. 1), 1-160 (2004).
6. Gourfinkel-An I, Baulac S, Nabbout R et al. Monogenic idiopathic epilepsies. Lancet Neurol. 3, 209-218 (2004).
7. Stam AH, van den Maagdenberg AMJM, Haan J, Terwindt GM, Ferrari MD. Genetics of migraine: an update with special attention for genetic co-morbidity. Curr. Opin. Neurol. 21, 288-293 (2008). • An update of recent developments in the field of migraine genetics.
8. Stam AH, Vanmolkot KR, Kremer HP et al. CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine. Clin. Genet. (2008) (Epub ahead of print).
9. Vanmolkot KR, Kors EE, Hottenga JJ et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54, 360-366 (2003).
10. Lebas A, Guyant-Marechal L, Hannequin D, Riant F, Tournier-Lasserve E, Parain D. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia 28(7), 774-777 (2008).
11. Deprez L, Weckhuysen S, Peeters K et al. Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia 49, 500-508 (2008). • A mutation analysis of 20 families with epilepsy and migraine.
12. Martinelli BF, Aridon P, Zara F et al. No evidence of ATP1A2 involvement in 12 multiplex Italian families with benign familial infantile seizures. Neurosci. Lett. 388, 71-74 (2005).
13. Buono RJ, Ferraro TN, O'Connor MJ et al. Lack of association between temporal lobe epilepsy and a novel polymorphism in the ?2 subunit gene (ATP1A2) of the sodium potassium transporting ATPase. Am. J. Med. Genet. 96, 79-83 (2000).
14. Lohoff FW, Ferraro TN, Sander T et al. No association between common variations in the human α2 subunit gene (ATP1A2) of the sodium-potassium-transporting ATPase and idiopathic generalized epilepsy. Neurosci. Lett. 382, 33-38 (2005).
15. Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371-377 (2005).
16. Vanmolkot KR, Babini E, de Vries BB et al. The novel L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Hum. Mut. 28, 522 (2007).
17. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 5, 148-157 (2006). • Review of migraine and epilepsy.
18. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia 27, 1429-1439 (2007).
19. Curra A, Pierelli F, Coppola G et al. Shortened cortical silent period in facial muscles of patients with migraine. Pain 132, 124-131 (2007).
20. Siniatchkin M, Moeller F, Sheperd A, Siebner H, Stephani U. Altered cortical visual processing in individuals with a spreading photoparoxysmal EEG response. Eur. J. Neurosci. 26, 529-536 (2007).
21. Steinlein OK. Genetic mechanisms that underlie epilepsy. Nat. Rev. Neurosci. 5, 400-408 (2004).
22. Van de Ven RCG, Kaja S, Plomp JJ, Frants RR, Van den Maagdenberg AMJM, Ferrari MD. Genetic models of migraine. Arch. Neurol. 64, 643-646 (2007).
23. Hadjikhani N, Sanchez del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA 98, 4687-4692 (2001).
24. Gorji A, Speckmann EJ. Spreading depression enhances the spontaneous epileptiform activity in human neocortical tissues. Eur. J. Neurosci. 19, 3371-3374 (2004).
25. Koch UR, Musshoff U, Pannek HW et al. Intrinsic excitability, synaptic potentials, and short-term plasticity in human epileptic neocortex. J. Neurosci. Res. 80, 715-726 (2005).
26. De Simone R, Ranieri A, Marano E et al. Migraine and epilepsy: Clinical and pathophysiological considerations. Neurol. Sci. 28, S150-S155 (2007).
27. Burstein R, Yarnitsky D, Goor-Arych I et al. An association between migraine and cutaneous allodynia. Ann. Neurol. 47, 614-624 (2000).
28. Bergerot A, Holland PR, Akerman S et al. Animal models of migraine: looking at the component parts of a complex disorder. Eur. J. Neurosci. 24, 1517-1534 (2006). • Review of animal models in migraine
29. Tokuda S, Kuramoto T, Tanaka K et al. The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel α-1A subunit gene and exhibits absence seizures. Brain Res. 1133, 168-177 (2007).
30. Ayata C, Shimizu-Sasamata M, Lo EH, Noebels JL, Moskowitz MA. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the α1A subunit of P/Q type calcium channels. Neuroscience 95, 639-645 (2000).
31. Van den Maagdenberg AMJM, Pietrobon D, Pizzorusso T et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701-710 (2004).
32. Yu FH, Mantegazza M, Westenbroek RE et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9, 1142-1149 (2006).
33. Ogiwara I, Miyamoto H, Morita N et al. Nav1.1 Localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 27, 5903-5914 (2007).
34. Kearney JA, Plummer NW, Smith MR et al. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 102, 307-317 (2001).
35. Calabresi P, Galletti F, Rossi C, Sarchielli P, Cupini LM. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanism. Trends Pharmacol. Sci. 28, 188-195 (2007). • Focuses on antiepileptic drugs used in migraine.
36. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann. Neurol. 59, 652-661 (2006). • Study of effect of antiepileptic drugs on spreading depression in migraine.
37. Kaczmarek LK. Non-conducting functions of voltage-gated ion channels. Nat. Rev. Neurosci. 7, 761-771 (2006).
38. Ashcroft FM. From molecule to malady. Nature 440, 440-447 (2006).